06/09/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/9/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Illumina COVIDSeq Test. The Illumina COVIDSeq Test is authorized for use with respiratory specimens collected from individuals who are suspected to have of COVID-19 by their healthcare provider. (PDF)
06/09/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/9/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the HDPCR™ SARS-CoV-2 Assay. The HDPCR™ SARS-CoV-2 Assay is authorized for use with respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
06/09/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 6/9/2020. Speakers in this one-hour webinar outline environmental cleaning and disinfectant procedures for frequent high-touch areas and devices such as face shields, stethoscopes, and other equipment. They discuss characteristics of COVID-19, including principles of transmission and precautions to take when working with soiled linens, bodily fluid spills, and other potential infectious modes of transmission. (Video or Multimedia)
06/08/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of Dimension Vista SARS-CoV-2 Total Antibody Assay (COV2T) (Dimension Vista COV2T). Dimension Vista COV2T is authorized for the detection of total antibodies (including IgG and IgM) to SARS-CoV-2 in human serum and plasma (dipotassium EDTA and lithium heparin). (PDF)
06/08/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of Dimension EXL SARS-CoV-2 Total Antibody Assay (CV2T) (Dimension EXL CV2T). Dimension EXL CV2T is authorized for the detection of total antibodies (including IgG and IgM) to SARS-CoV-2 in human serum and plasma (dipotassium EDTA and lithium heparin). (PDF)
06/08/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 6/8/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the EURORealTime SARS-CoV-2. The EURORealTime SARS-CoV-2 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
06/08/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 6/8/2020. This document provides a foundation on which the U.S. Government and its partners can contribute to a common vision of a domestic influenza vaccine enterprise – one that is highly responsive, flexible, scalable, and more effective at reducing the impact of seasonal and pandemic influenza viruses. (Text)
06/01/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 6/2020. This 20-page report summarizes data collected by summarizes data collected by the Global Analysis and Assessment of Sanitation and Drinking-Water (GLAAS) initiative on how governments and external support agencies are supporting hygiene, including information on national policies, plans, targets, and finance. Main findings include that countries have national policies and plans for hygiene; however, they lack the financial and human resources to fully implement them, and household expenditures on hygiene are high compared to government expenditure. (PDF)
06/01/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/1/2020. This web page details why refugees may be at higher risk during COVID-19 outbreaks, and what can be done for refugee health by public health officials, community organizations and resettlement agencies, and healthcare systems and providers during COVID-19 outbreaks. (Text)
06/01/2020 12:00 AM EDT
Source: American Society of Hematology (ASH). Published: 6/2020. In response to the emergence of hematologic complications from COVID-19 infection, the American Society of Hematology has developed this COVID-19 Research Agenda in Hematology. This living document represents fundamental questions that experts in hematology and blood research deem of critical importance to researchers, physicians, and patients. (Text)
06/01/2020 12:00 AM EDT
Source: United Nations, World Meteorological Organization (WMO). Published: 6/2020. This 44-page report outlines the latest climate science and illustrates the urgency for far-reaching climate action. It brings together data from across the fields of climate science and lists the potential future impacts of climate change – from health at increasing risk and economic consequences to decreased food security and increased displacement. (PDF)
05/15/2020 12:00 AM EDT
Source: United Kingdom Department for International Development (DFID). Published: 5/15/2020. This 28-page report provides an overview of the physical distancing measures that have been implemented in South Asian countries to date and recommendations on approaches that can be employed to prevent the spread of COVID-19, with a specific set of recommendations for India. (PDF)
05/01/2020 12:00 AM EDT
Source: U.S. Environmental Protection Agency, Office of Research and Development, National Homeland Security Research Center (NHSRC). Published: 5/2020. In the event of a chemical release incident involving chemical warfare agents (CWAs), porous building materials and permeable coatings may become contaminated with CWAs that absorb into the materials and coatings. This 102-page report discusses the results of two technologies/approaches that were selected for bench-scale laboratory studies, followed by subsequent experimental evaluation of physical removal efficacy of VX. (PDF)
05/01/2020 12:00 AM EDT
Source: Well Being Trust (WBT). Published: 5/2020. The goal of this 12-page report is to predict what deaths of despair might be seen based on three assumptions during COVID-19: economic recovery, relationship between deaths of despair and unemployment, and geography. (PDF)
.png)
No hay comentarios:
Publicar un comentario